Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT02972372

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

Led by The First Affiliated Hospital of Henan University of Science and Technology · Updated on 2025-02-10

196

Participants Needed

2

Research Sites

578 weeks

Total Duration

On this page

Sponsors

T

The First Affiliated Hospital of Henan University of Science and Technology

Lead Sponsor

J

Jiangsu HengRui Medicine Co., Ltd.

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of this study is to compare outcomes in Chinese patients with locally advanced resectable esophageal squamous cell cancer who have received either surgery or definitive chemoradiation (CRT) by the randomized, open-label, multicenter trial.

CONDITIONS

Official Title

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Chinese ethnicity
  • Diagnosed with esophageal squamous cell cancer
  • Cancer located in the mid or lower esophagus
  • Tumor is considered resectable
  • Clinical stage cT1bN+M0 or cT2-4aN0-2M0
Not Eligible

You will not qualify if you...

  • Presence of distant metastasis to solid visceral organs
  • Local invasion into trachea, descending aorta, or recurrent laryngeal nerve
  • Serious pre-existing conditions or poor physical status that prevent thoracotomy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Anyang Tumor Hospital

Anyang, Henan, China

Actively Recruiting

2

The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology

Luoyang, Henan, China, 471003

Actively Recruiting

Loading map...

Research Team

S

Shegan Gao, MD, PhD

CONTACT

R

Ruinuo Jia, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here